Breath Therapeutics

Climate protection contribution1,260.0 t CO2
Partner since2019
Status active

Our company profile

Breath is a German/US Biotech company specializing in first-in-class therapies for rare respiratory diseases with fatal outcome and high unmet medical need. For its clinical development, the Company is using new proprietary drug formulations optimized for inhaled administration with exclusively licensed, high performance nebulizers. Breath is focusing on integrated therapy solutions in the interaction between diagnostics, therapeutics and eHealth therapy monitoring.

Blue Planet Certificate BPC181BR

Supported projects

Green Climate Bridge in Costa Rica

Trees: 95,118

Afforestation in the Andes

Trees: 51,322

Company Website


Breath Therapeutics
Frankfurt / Munich / San Francisco